Article
Nestlyy} SA might sell 25% ofAlcon if it decides to do a partial initial public offering of the unitnext year, according to CEO Peter Brabeck-Letmathe.
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.